Abstract:Molecular medicine is an emerging field focused on understanding the molecular basis of diseases and translating this information into strategies for diagnosis and therapy. This approach could lead to personalized medical treatments. Currently, our ability to understand human diseases at the molecular level is limited by the lack of molecular tools to identify and characterize the distinct molecular features of the disease state, especially for diseases such as cancer. Among the new tools being developed by researchers including chemists, engineers, and other scientists is a new class of nucleic acid probes called aptamers, which are ssDNA/RNA molecules selected to target a wide range of molecules and even cells. In this Account, we will focus on the use of aptamers, generated from cell-based selections, as a novel molecular tool for cancer research. Cancers originate from mutations of human genes. These genetic alterations result in molecular changes to diseased cells, which, in turn, lead to changes in cell morphology and physiology. For decades, clinicians have diagnosed cancers primarily based on the morphology of tumor cells or tissues. However, this method does not always give an accurate diagnosis and does not allow clinicians to effectively assess the complex molecular alterations that are predictive of cancer progression. As genomics and proteomics do not yet allow a full access to this molecular knowledge, aptamer probes represent one effective and practical avenue toward this goal. One special feature of aptamers is that we can isolate them by selection against cancer cells without prior knowledge of the number and arrangement of proteins on the cellular surface. These probes can identify molecular differences between normal and tumor cells and can discriminate among tumor cells of different classifications, at different disease stages, or from different patients. This Account summarizes our recent efforts to develop aptamers through cell-SELEX for the study of cancer and apply those aptamers in cancer diagnosis and therapy. We first discuss how we select aptamers against live cancer cells. We then describe uses of these aptamers. Aptamers can serve as agents for molecular profiling of specific cancer types. They can also be used to modify therapeutic reagents to develop targeted cancer therapies. Aptamers are also aiding the discovery of new cancer biomarkers through the recognition of membrane protein targets. Importantly, we demonstrate how molecular assemblies can integrate the properties of aptamers and, for example, nanoparticles or microfluidic devices, to improve cancer cell enrichment, detection and therapy.

Cell-SELEX-based Aptamer-Conjugated Nanomaterials for Cancer Diagnosis and Therapy

Cell-SELEX-based Aptamer-Conjugated Nanomaterials for Enhanced Targeting of Cancer Cells

Using Aptamer–Nanoparticle Conjugates for Cancer Cells Detection

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

Novel Insights into the Role of Aptamers in the Fight Against Cancer.

The application progress in cell-SELEX-based aptamers in cancer

Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review

Aptamer-conjugated Nanomaterials for Specific Cancer Cell Recognition and Targeted Cancer Therapy.

Aptamer-Conjugated Nanoparticles for Cancer Cell Detection

Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX.

Progress on Aptamer for Cancer Theranostics

Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology

Aptamers Selected By Cell-Selex For Application In Cancer Studies

Aptamers: Versatile Molecular Recognition Probes for Cancer Detection.

Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics

Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics.

Aptamers Selected by Cell-SELEX for Molecular Imaging

Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach

Aptamer-conjugated Nanomaterials and Their Applications

Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells

Applications of Aptamer-Bound Nanomaterials in Cancer Therapy